Trial Profile
Ziprasidone in the treatment of borderline personality disorder: A double-blind, placebo-controlled, randomized study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary)
- Indications Borderline personality disorders
- Focus Therapeutic Use
- 03 Apr 2008 New trial record.